Co-Authors
This is a "connection" page, showing publications co-authored by James Wachira and Santosh Mandal.
Connection Strength
0.786
-
Varisli B, Wachira J, Mandal S. Imaging the Cellular Distribution of Amino Acid Derivatives of Tricarbonylrhenium(I) 1, 10-orthophenanthroline Compounds. Microsc Microanal. 2023 Jul 22; 29(29 Suppl 1):1130-1132.
Score: 0.240
-
Wilder PT, Weber DJ, Winstead A, Parnell S, Hinton TV, Stevenson M, Giri D, Azemati S, Olczak P, Powell BV, Odebode T, Tadesse S, Zhang Y, Pramanik SK, Wachira JM, Ghimire S, McCarthy P, Barfield A, Banerjee HN, Chen C, Golen JA, Rheingold AL, Krause JA, Ho DM, Zavalij PY, Shaw R, Mandal SK. Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells. Mol Cell Biochem. 2018 Apr; 441(1-2):151-163.
Score: 0.160
-
Parson C, Smith V, Krauss C, Banerjee HN, Reilly C, Krause JA, Wachira JM, Giri D, Winstead A, Mandal SK. Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines. Br J Pharm Res. 2015 Feb 01; 4(3):362-367.
Score: 0.133
-
Medley J, Payne G, Banerjee HN, Giri D, Winstead A, Wachira JM, Krause JA, Shaw R, Pramanik SK, Mandal SK. DNA-binding and cytotoxic efficacy studies of organorhenium pentylcarbonate compounds. Mol Cell Biochem. 2015 Jan; 398(1-2):21-30.
Score: 0.130
-
Parson C, Smith V, Krauss C, Banerjee HN, Reilly C, Krause JA, Wachira JM, Giri D, Winstead A, Mandal SK. The effect of novel rhenium compounds on lymphosarcoma, PC-3 prostate and myeloid leukemia cancer cell lines and an investigation on the DNA binding properties of one of these compounds through electronic spectroscopy. J Bioprocess Biotech. 2013 Dec 27; 4(1):141.
Score: 0.123